We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Consensus and Guidelines · June 28, 2020

Management of Autoimmune Bullous Diseases During the COVID-19 Pandemic

Journal of the European Academy of Dermatology and Venereology: JEADV

 

Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
Expert Recommendations for the Management of Autoimmune Bullous Diseases During the COVID-19 Pandemic
J Eur Acad Dermatol Venereol 2020 Apr 25;[EPub Ahead of Print], M Kasperkiewicz, E Schmidt, JA Fairley, P Joly, AS Payne, ML Yale, D Zillikens, DT Woodley

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading